(Q43037497)

English

Role of interleukin 28B rs12979860 C/T polymorphism on the histological outcome of chronic hepatitis C: relationship with gender and viral genotype.

scientific article published on 7 June 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647799%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Role of interleukin 28B rs12979860 C/T polymorphism on the histological outcome of chronic hepatitis C: relationship with gender and viral genotype (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647799%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

0 references

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647799%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647799%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Pierluigi Toniutto

13

object named as

Pierluigi Toniutto

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647799%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

3

object named as

Carlo Fabris

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647799%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

Edmondo Falleti

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647799%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Davide Bitetto

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647799%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Annarosa Cussigh

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647799%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Ezio Fornasiere

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647799%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Sara Cmet

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647799%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Elisa Fumolo

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647799%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Sara Bignulin

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647799%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Elisabetta Fontanini

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647799%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Rosalba Minisini

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647799%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

publication date

7 June 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647799%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Journal of Clinical Immunology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647799%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

31

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647799%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647799%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

891-899

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647799%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

https://scigraph.springernature.com/pub.10.1007/s10875-011-9547-1

0 references

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9547-1

21 January 2018

Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9547-1

21 January 2018

Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9547-1

21 January 2018

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9547-1

21 January 2018

Hepatitis C virus infection in African Americans

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9547-1

21 January 2018

Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9547-1

21 January 2018

Treatment of chronic hepatitis C in elderly patients

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9547-1

21 January 2018

Treatment predictors of a sustained virologic response in hepatitis B and C.

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9547-1

21 January 2018

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9547-1

21 January 2018

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9547-1

21 January 2018

Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9547-1

21 January 2018

IL28B and the control of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9547-1

21 January 2018

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9547-1

21 January 2018

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9547-1

21 January 2018

Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9547-1

21 January 2018

Interleukin-28B genetic variants and hepatitis virus infection by different viral genotypes

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9547-1

21 January 2018

Treatment of chronic hepatitis C in Asia: when East meets West.

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9547-1

21 January 2018

Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9547-1

21 January 2018

The effect of 17beta-estradiol on production of cytokines in cultures of peripheral blood.

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9547-1

21 January 2018

Interleukin-6 polymorphisms and gender: relationship with the occurrence of hepatocellular carcinoma in patients with end-stage liver disease.

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9547-1

21 January 2018

Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9547-1

21 January 2018

Lambda interferon inhibits hepatitis B and C virus replication

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9547-1

21 January 2018

Lambda interferon inhibits human immunodeficiency virus type 1 infection of macrophages

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9547-1

21 January 2018

Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9547-1

21 January 2018

IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: Role in the course of chronic viral hepatitis and the development of HCC

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9547-1

21 January 2018

Natural history of hepatitis C

1 reference

https://pubmed.ncbi.nlm.nih.gov/21647799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43037497&oldid=1879138099"